OncoPep to start multiple myeloma vaccine trial
This article was originally published in Scrip
Executive Summary
OncoPep, a small biotechnology start-up, is going to begin clinical testing with PVX-410, its lead multi-peptide therapeutic cancer vaccine designed to target specific antigens found on the surface of multiple myeloma cancer cells